HOME >> BIOLOGY >> NEWS
Reduced fish stocks linked to increased bushmeat trade, wildlife declines in W. Africa

Declining fish stocks are fuelling a multibillion-dollar bushmeat trade in West Africa. It's a trend that is threatening the survival of dozens of wildlife species, and EU fishing agreements with African nations may be part of the problem, says a group of international researchers that includes UBC forestry sciences professor Peter Arcese, UBC zoology professor Anthony Sinclair and UBC graduate Justin Brashares (now an assistant professor at UC, Berkeley).

Using 30 years worth of census data collected monthly by rangers in six nature reserves in Ghana, the researchers have found a direct link between fish supply and the demand for bushmeat in Ghanaian villages. Bushmeat is any wild species taken from public land and sold for consumption.

The group's findings will be published in November 12 issue of the journal Science.

More than half of Ghana's 20 million people reside within 100 km of the coast, where fish are the primary source of dietary protein and income.

Looking at data for the years 1970 to 1998, researchers found that in 14 local food markets, when fish supply was limited or its price increased, residents substituted bushmeat as an alternate source of affordable protein and the number of bushmeat hunters observed by rangers in parks increased. Overall, the wildlife harvest has contributed to a 76 per cent decline in the biomass of 41 species of mammals in parks since 1970.

The bushmeat trade in Ghana is estimated conservatively at 400,000 tons per year. Species affected include several species of antelope, carnivores and small primates.

During the same period, trawl surveys conducted in the Gulf of Guinea, off Ghana's coast, since 1970 along with other regional stock assessments, estimate that fish biomass in nearshore and offshore waters has declined by at least 50 per cent. In the same period, there has been a threefold increase in human populations in the region.

"We've suspected this
'"/>

Contact: Michelle Cook
michelle.cook@ubc.ca
1-604-822-2048
University of British Columbia
11-Nov-2004


Page: 1 2 3

Related biology news :

1. Reduced frontal-lobe activity and impulsivity may be linked to alcoholism risk
2. Reduced body temperature extends lifespan in study from the Scripps Research Institute
3. Reduced calorie and carbohydrate diet slows progression of Alzheimers disease in mouse model
4. Innovative tagging technique may help researchers better protect fish stocks
5. High-value chemicals produced from ethanol feedstocks could boost biorefinery economics
6. Salmon go veggie to save wild fish stocks
7. Marine ecologists to help rebuild decreasing fish stocks
8. Darwinian debt may explain why fish stocks dont recover
9. Big, old fish key to restoring groundfish stocks
10. Studies in Royal Society journals include stress in birds and depletion of medieval fish stocks
11. Protein chatter linked to cancer activation

Post Your Comments:
(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
(Date:12/17/2014)... Xeno Diagnostics has again received ... recent COLA inspection. Xeno has met all criteria ... accreditation organization. Accreditation is earned only by laboratories ... operations, demonstrate continued accuracy in the performance of ... survey. , While the Laboratory Excellence ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a primary commercial focus on ... has been granted a Type C meeting with the ... meeting will be held in February 2015.  During this ...
(Date:12/15/2014)... DIEGO , Dec. 15, 2014 ... three-dimensional biology company focused on delivering breakthrough 3D ... the industry and collaborators of its exVive3D TM ... made widely available in full commercial release on ... the field, resulting in several awards for innovation. ...
(Date:12/13/2014)... and Virgin Unite Canada, the non-profit foundation of the Virgin ... Canadian entrepreneurs tackling social and environmental challenges. Today, Sir ... Centre to announce the new partnership, which includes the development ... $1 million in seed capital provided by Virgin Unite Canada ... Foundation, founded by Alison Lawton . ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3
Cached News: